Your session is about to expire
← Back to Search
Patient Partnership Tools for Patient Engagement (PROMIS Trial)
N/A
Recruiting
Led By Yan Xiao, PhD
Research Sponsored by The University of Texas at Arlington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 4 hours after primary care visit (one time assessment)
Awards & highlights
PROMIS Trial Summary
This trial assesses how two tools help patients and providers communicate & make decisions together.
Who is the study for?
The PROMIS trial is for people who live at home, are aged 50 or older, take five or more medications, and speak English or Spanish. It's not for those in nursing facilities, with impaired decision-making abilities, or who don't consent to participate.Check my eligibility
What is being tested?
This study tests two tools designed to help patients engage better with their healthcare providers: a 'visit prep guide' to improve communication during appointments and educational videos aimed at empowering patients in managing their health.See study design
What are the potential side effects?
Since the interventions are non-medical patient partnership tools (a guide and videos), they do not have physical side effects like drugs. However, there may be indirect effects on how patients interact with healthcare providers.
PROMIS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 4 hours after primary care visit (one time assessment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 4 hours after primary care visit (one time assessment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medication use and self-efficacy
Secondary outcome measures
Medication regimen problems
PROMIS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Patient partnership toolExperimental Treatment1 Intervention
Study participants as patients visiting primary care providers in the clinics using the study patient engagement tools aimed to reduce preventable adverse drug events.
Group II: ControlActive Control1 Intervention
Study participants as patients visiting primary care providers in the clinics without the study patient engagement tools.
Find a Location
Who is running the clinical trial?
The University of Texas at ArlingtonLead Sponsor
43 Previous Clinical Trials
4,438 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,821,848 Total Patients Enrolled
Yan Xiao, PhDPrincipal InvestigatorUniversity of Texas at Arlington
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not speak English or Spanish.I have difficulty making decisions due to my health condition.I am 50 years old or older.I am taking 5 or more medications.I speak English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Patient partnership tool
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still any open slots available for participants in this experiment?
"That is correct. The clinical trial details found onclinicaltrials.gov demonstrate that this study, which was originally posted on June 26th 2023, is actively looking for participants to enroll in the program. 500 patients must be recruited from 2 different sites."
Answered by AI
How many participants are involved in the current experiment?
"Affirmative. According to clinicaltrials.gov, this treatment trial is currently recruiting patients and was initially posted on June 26th 2023 with the latest update being July 19th 2023. The study requires 500 participants between two locations."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger